Myelomeningocele Clinical Trial
Official title:
Assessment of Maternal Blood Gas Changes When Using Atosiban and Terbutaline as Tocolytic Agents, During in Utero Repair of Myelomeningocele
Myelomeningocele is a malformation with high incidence, and it consists in a neural tube defect. Fetal intrauterine surgery is an alternative for correction, and it improves the prognosis of the fetus, but has an increased risk of maternal complications and premature labor, as it can occur due to uterine stimulation. It is therefore essential that tocolysis is performed before, during and after surgery, and the most commonly used tocolytics are terbutaline and atosiban. Terbutaline has no specificity and may have several adverse effects such as maternal acidosis.
The objective of the study was to evaluate maternal blood gas alterations among cases that used atosiban tocolytic agent and cases with terbutaline in in utero repair of myelomeningocele. It consists of a retrospective cohort study. It included 25 patients, who were divided into two groups, depending on which agent they received as main tocolytic agent during the intrauterine fetal myelomeningocele repair: terbutalineor atosiban. The primary outcome was maternal arterial pH at the end of surgery. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06042140 -
Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair
|
N/A | |
Recruiting |
NCT03562286 -
Open Spina Bifida Fetoscopic Repair Project
|
N/A | |
Recruiting |
NCT04362592 -
In-Utero Endoscopic Correction of Spina Bifida
|
N/A | |
Recruiting |
NCT03856034 -
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
|
N/A | |
Active, not recruiting |
NCT03936322 -
Minimally Invasive Fetoscopic Regenerative Repair of Spina Bifida - A Pilot Study
|
N/A | |
Not yet recruiting |
NCT06405698 -
Role of Perforator Flaps in Back Defects Reconstruction
|
N/A | |
Active, not recruiting |
NCT00175123 -
Effect of Botulinum Toxin in Neurogenic Bladders in Children With Myelomeningocele
|
Phase 4 | |
Completed |
NCT02390895 -
Prenatal Endoscopic Repair of Fetal Spina Bifida
|
N/A | |
Active, not recruiting |
NCT03090633 -
Fetoscopic Repair of Isolated Fetal Spina Bifida
|
N/A | |
Not yet recruiting |
NCT03088761 -
Cuff Pressure in Infants
|
N/A | |
Active, not recruiting |
NCT04484441 -
Maternal-fetal Immune Responses to Fetal Surgery
|
||
Recruiting |
NCT04738539 -
Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies
|
||
Recruiting |
NCT04652908 -
Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial
|
Phase 1/Phase 2 | |
Terminated |
NCT02493062 -
Evaluation of Hysterotomy Site After Open Fetal Surgery
|
N/A | |
Completed |
NCT03550898 -
Can Dynamic Ultrasonography Replace Urodynamics in Follow-up of Patients With Myelomeningocele
|
N/A | |
Active, not recruiting |
NCT04251806 -
Sleep-disordered Breathing in Infants With Myelomeningocele
|
||
Terminated |
NCT02509377 -
Fetal Myelomeningocele Repair With Maternal BMI Between 35.0 and 40.0
|
N/A | |
Recruiting |
NCT03788122 -
Fetal Surgery Interview Study: Parental Perceptions of Fetal Surgery
|
N/A | |
Completed |
NCT02664207 -
Extended Criteria For Fetal Myelomeningocele Repair
|
N/A | |
Recruiting |
NCT03315637 -
Fetal Endoscopic Surgery for Spina Bifida
|
N/A |